About Astral SteriTech
Astral SteriTech is a company based in Vadodara (India) founded in 1991 was acquired by Centrient Pharmaceuticals in February 2021. The company has 103 employees. Astral SteriTech operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
- Headquarter Vadodara, India
- Employees 103
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website astralsteritech.com
- Social LinkedIn
- Acquired by Centrient Pharmaceuticals (Feb 2021)
- Legal Name Astral Steritech Private Limited
- Date of Incorporation 03 Sep, 2012
- Jurisdiction Vadodara, Gujarat, India
- Annual Revenue₹202 Cr
FY 2022 · -36% YoY
- Net Profit₹30.71 Cr
FY 2022 · 15% margin
- EBITDA₹49.40 Cr
FY 2022 · 25% margin
- Investors
- Employee Count103
- Acquired byCentrient Pharmaceuticals
(Feb 2021)
Associated legal entities of Astral SteriTech
Astral SteriTech operates through Astral Steritech Private Limited (under cirp). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Astral Steritech Private Limited CIN U24100GJ2012PTC071810 | Under Cirp | 03 Sep 2012 | Vadodara, Gujarat | ₹202 Cr | 103 | 6 | View details |
Investors in Astral SteriTech
Astral SteriTech has secured backing from 1 investor. Prominent investors backing the company include Centrient Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Active pharmaceutical ingredients and finished dosage forms are manufactured. | 1869 | centrient.com | Rotterdam, Netherlands |
Investor details for Astral SteriTech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Astral Steritech Private Limited (Astral SteriTech)
Astral Steritech Private Limited is the primary company behind Astral SteriTech. The board of Astral Steritech Private Limited currently have 6 directors; the longest-serving is Rohan Dheman, appointed in 2022. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rohan Dheman DIN 09505040 | Director | 07 Mar 2022 | 4 yrs 7 mo | Astral Steritech Private Limited |
| Nitish Niharkumar Chakravarty DIN 07998951 | Director | 06 Sep 2022 | 4 yrs 1 mo | Astral Steritech Private Limited |
| Kiran Mohanlal Jain DIN 08241177 | Additional Director | 09 Jun 2025 | 1 yr 4 mo | Astral Steritech Private Limited |
| Uttamkumar Mohanlal Jain DIN 02536595 | Additional Director | 09 Jun 2025 | 1 yr 4 mo | Astral Steritech Private Limited |
| Devangiben Jigneshkumar Shah DIN 09303600 | Additional Director | 09 Jun 2025 | 1 yr 4 mo | Astral Steritech Private Limited |
| Jigneshkumar Ashvinbhai Shah DIN 03113210 | Additional Director | 09 Jun 2025 | 1 yr 4 mo | Astral Steritech Private Limited |
Financials of Astral SteriTech
Figures of Astral Steritech Private Limited, the primary company behind Astral SteriTech, for FY 2022. Revenue was ₹202 Cr (-36% year on year). Net profit was ₹30.71 Cr (15% margin). EBITDA was ₹49.40 Cr (25% margin). Revenue has grown at a compounded annual rate of -6% over three years and +5% over five years.
- ₹202 CrRevenue · FY 2022 · -36% YoY
- ₹30.71 CrNet profit · 15% margin
- ₹49.40 CrEBITDA · 25% margin
- ₹1.00 CrPaid-up capital
- 103Employees (provident fund records)
- -6%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Astral Steritech Private Limited are on its company page.
Detailed financial statements for Astral SteriTech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Astral SteriTech
2 dated milestones of Astral SteriTech across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Astral SteriTech is founded.
- Exit Acquired by Centrient Pharmaceuticals.
Competitors of Astral SteriTech
Astral SteriTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $255.15M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| zuelligpharma.com | 1992 | Singapore | – | – | Healthcare access in Asia is enhanced by Zuellig Pharma. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clinigengroup.com | 2010 | Burton-on-trent, United Kingdom | – | – | Specialty medicines are supplied via clinical trials and access programs. | |
| sciencegroup.com | 1995 | Cambridge, United Kingdom | – | 431 | Technology-based consultancy and product development services are provided. | |
| clearviewhcp.com | 2008 | Newton, United States | – | 381 | Strategic consulting services are provided to life sciences companies. | |
| fabtechnologies.com | 2002 | Mumbai, India | $175,048 | 279 | Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured. |
Detailed competitors of Astral SteriTech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Astral Steritech
Complete news archive for Astral SteriTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Astral SteriTech
10 companies that operate in the same segment as Astral SteriTech (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Astral SteriTech
Astral SteriTech was founded in 1991.
Astral SteriTech is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Astral SteriTech has 103 employees.
The primary company behind Astral SteriTech, Astral Steritech Private Limited, reported revenue of ₹202 Cr for FY 2022, down 36% year on year.
Astral SteriTech was established in 1991 and is headquartered in Vadodara, India. Services in regulatory compliance and quality management are delivered to companies in the biopharma sector. Operations encompass consulting on standards adherence, documentation support, and process optimization. Focus remains on assisting firms with international regulations and internal quality systems, primarily within the Indian market and select global clients.
Astral SteriTech's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Astral SteriTech has 1 investor. Key investors include Centrient Pharmaceuticals.
Astral SteriTech operates through Astral Steritech Private Limited.
Yes. Astral SteriTech was acquired by Centrient Pharmaceuticals in February 2021.
The legal entities of Astral SteriTech currently have 6 directors, including Nitish Niharkumar Chakravarty, Kiran Mohanlal Jain, Uttamkumar Mohanlal Jain and others.